Following the first regulatory approval of a CRISPR-based drug in late 2023, over ten years since the CRISPR-Cas9 system was elucidated, there is considerable optimism about the future potential for gene editing technologies.

The astonishing pace of innovation has led to new, potentially safer CRISPR-based techniques, including base editing, prime editing and epigenome editing, and researchers are moving beyond the Cas9 system to Cas12 and other proteins, opening the realms of possibilities for genomic editing.

This 24-page eBook, sponsored by Scale Biosciences, explores the latest innovations in gene editing and CRISPR, the possibilities of new editing techniques and where the greatest potential for the technology might lie in the future.

Download this exclusive eBook to learn more about:

• How CRISPR is providing new solutions for common diseases
• The potential of base editing in stem cell-based therapies
• Where CRISPR-based gene editing techniques could take us next